000 | 03418nam a22003855i 4500 | ||
---|---|---|---|
001 | 289544 | ||
003 | MX-SnUAN | ||
005 | 20160429154714.0 | ||
007 | cr nn 008mamaa | ||
008 | 150903s2009 xxu| o |||| 0|eng d | ||
020 |
_a9781597454117 _99781597454117 |
||
024 | 7 |
_a10.1007/9781597454117 _2doi |
|
035 | _avtls000343090 | ||
039 | 9 |
_a201509030901 _bVLOAD _c201405050251 _dVLOAD _y201402061147 _zstaff |
|
040 |
_aMX-SnUAN _bspa _cMX-SnUAN _erda |
||
050 | 4 | _aRC681-688.2 | |
100 | 1 |
_aWang, Andrew. _eeditor. _9319812 |
|
245 | 1 | 0 |
_aValvular Heart Disease / _cedited by Andrew Wang, Thomas M. Bashore. |
264 | 1 |
_aTotowa, NJ : _bHumana Press, _c2009. |
|
300 |
_ax, 535 páginas _brecurso en línea. |
||
336 |
_atexto _btxt _2rdacontent |
||
337 |
_acomputadora _bc _2rdamedia |
||
338 |
_arecurso en línea _bcr _2rdacarrier |
||
347 |
_aarchivo de texto _bPDF _2rda |
||
490 | 0 | _aContemporary Cardiology | |
500 | _aSpringer eBooks | ||
505 | 0 | _aMorphologic Aspects of Valvular Heart Disease -- Cellular Pathogenesis of Degenerative Valvular Heart Disease: From Calcific Aortic Stenosis to Myxomatous Mitral Valve Disease -- Ventricular Adaptation to Valvular Heart Disease -- Physical Examination in Valvular Heart Disease -- Clinical Hemodynamics in Valvular Heart Disease -- Echocardiographic Assessment of Native Valve Function -- Aortic Stenosis -- Aortic Regurgitation -- Mitral Stenosis -- Mitral Regurgitation -- Tricuspid Stenosis and Regurgitation -- Pulmonary Valve Stenosis and Regurgitation -- Contemporary Considerations in Aortic Valve Surgery -- Contemporary Considerations in Mitral Valve Surgery -- Surgery of the Tricuspid and Pulmonary Valves -- Medical Therapy of Valvular Heart Disease -- Percutaneous Valve Replacement -- Percutaneous Balloon Valvuloplasty and Mitral Valve Repair -- Post-operative Care of the Patient Undergoing Valve Surgery -- Prosthetic Valve Dysfunction -- Infective Endocarditis -- Exercise and Noncardiac Surgery in Valvular Heart Disease -- Valvular Heart Disease and Pregnancy. | |
520 | _aChallenges for the treatment of valvular heart disease include the growing need for effective yet less invasive interventions and therapies to treat these progressive conditions. With the development of potential new treatments, it is crucial for cardiac physicians to be well informed on the pathophysiology, assessment, treatment options and their outcomes of valvular diseases. Written by a highly experienced and internationally recognized group of cardiologists, cardiac surgeons, and researchers, Valvular Heart Disease offers insights into the widely varying hemodynamic effects and clinical course of heart valve conditions, as well as the contemporary management of these conditions. Offering a broad perspective on these diseases, Valvular Heart Disease expands on the recent guidelines developed by the major heart societies in the United State and Europe. | ||
590 | _aPara consulta fuera de la UANL se requiere clave de acceso remoto. | ||
700 | 1 |
_aBashore, Thomas M. _eeditor. _9319813 |
|
710 | 2 |
_aSpringerLink (Servicio en línea) _9299170 |
|
776 | 0 | 8 |
_iEdición impresa: _z9781588299826 |
856 | 4 | 0 |
_uhttp://remoto.dgb.uanl.mx/login?url=http://dx.doi.org/10.1007/978-1-59745-411-7 _zConectar a Springer E-Books (Para consulta externa se requiere previa autentificación en Biblioteca Digital UANL) |
942 | _c14 | ||
999 |
_c289544 _d289544 |